Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Topics Community

Article

Impact of next generation sequencing results on clinical management in patients with hematological disorders.

Leukemia & lymphoma - 1 Jul 2021

Patel Bhumika J, Barot Shimoli V, Xie Yan, Cook James R, Carraway Hetty E, Hsi Eric D

Abstract excerpt

Application of next generation sequencing (NGS) has shed light on the molecular heterogeneity of hematological malignancies. NGS panels targeting recurrent mutations have become common in many large centers and commercial laboratories. However, its impact in clinical practice is unclear. We sought to characterize the use of NGS at a tertiary care center in an observational study of 343 patients with suspected...

Topics

Join the communities discussing this publication.

Hematologic Neoplasms
High-Throughput Nucleotide Sequencing
Molecular Diagnostic Techniques
Mutation

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 33533694
DOI: 10.1080/10428194.2021.1876860

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Impact of next generation sequencing results on clinical management in patients with hematological disorders.PMID 33533694Read ↗

The role of next-generation sequencing in hematologic malignanciesSemantic proximity Read ↗

Lessons from next-generation sequencing analysis in hematological malignanciesSemantic proximity Read ↗

Applications of next-generation sequencing in hematologic malignancies.Semantic proximity Read ↗

Challenges in the introduction of next-generation sequencing (NGS) for diagnostics of myeloid malignancies into clinical routine useSemantic proximity Read ↗

Routine next generation sequencing of lymphoid malignancies: clinical utility and challenges from a 3-Year practical experience.Semantic proximity Read ↗

Assessment of the clinical utility of four NGS panels in myeloid malignancies. Suggestions for NGS panel choice or design.Semantic proximity Read ↗

Next-generation sequencing in hypoplastic bone marrow failure: What difference does it make?Semantic proximity Read ↗

Current practices and guidelines for clinical next-generation sequencing oncology testing.Semantic proximity Read ↗

Next‐generation sequencing – feasibility and practicality in haematologySemantic proximity Read ↗

Analytical Validation of a 37-Gene Next-Generation Sequencing Panel for Myeloid Malignancies and Review of Initial Findings Incorporating Updated 2022 Diagnostic and Prognostic Guidelines.Semantic proximity Read ↗

Impact of integrated genetic information on diagnosis and prognostication for myeloproliferative neoplasms in the next-generation sequencing eraSemantic proximity Read ↗

Design, implementation and clinical utility of next generation sequencing in myeloid malignancies: acute myeloid leukaemia and myelodysplastic syndrome.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.